Inflammatory bowel disease after 1932.

Area of Science:

• Gastroenterology
• Inflammatory Bowel Disease (IBD) research

Background:

• Ulcerative colitis (UC) and Crohn's disease (CD) were clinically defined in the early 1930s.
• Major conceptual shifts included recognizing colonic involvement in regional enteritis and the occurrence of cancer and toxic megacolon in both CD and UC.

Observation:

• The latter half of the 20th century saw significant gastroenterology contributions to IBD at The Mount Sinai Hospital.
• Research focused on extra-intestinal manifestations, CD clinical activity measurement, placebo arm natural history, and complications.
• Therapeutic advancements included corticosteroids, 5-ASA, 6-mercaptopurine, immunomodulators, and cyclosporine.

Findings:

• Actuarial life tables were applied to analyze postoperative recurrence, re-operation rates, and quality of life.
• Two distinct forms of Crohn's disease were identified: perforating and non-perforating.
• The influence of the fecal stream on recurrence risk after surgery, particularly with anastomosis versus ileocolostomy, was investigated.

Implications:

• These findings have refined the understanding and management of IBD.
• The research provides a foundation for current and future IBD treatment strategies.
• Continued investigation into disease mechanisms and therapeutic interventions remains crucial for improving patient outcomes.